Le Lézard
Classified in: Health, Science and technology, Covid-19 virus

Global Therapeutic Antibody Market Forecast to Reach USD 428.20 Billion by 2029: In-Depth Analysis by Antibody Type, Source, and Application - ResearchAndMarkets.com

The "Global Therapeutic Antibody Market (2023 Edition): Analysis By Antibody Type (Monoclonal, Bispecific, Drug Conjugates, Others), Source (Fully human, Humanized, Others), By Application, By Region, By Country: Market Insights and Forecast (2019-2029)" report has been added to ResearchAndMarkets.com's offering.

Global Therapeutic Antibody Market reveals significant insights into market segmentation, including monoclonal antibodies, bispecific antibodies, and more. The study covers antibody sources like fully human and humanized antibodies, and applications such as oncology and autoimmune diseases.

This in-depth report examines the forecast growth trends and market dynamics from 2024 to 2029, with a specific focus on key regions and countries contributing to the global market expansion. The report identifies a robust compound annual growth rate (CAGR) of 11.21% during the forecast period.

Highlighted within the report are the key drivers influencing the market's trajectory, including the rising prevalence of chronic diseases and the leap forward in personalized medicine. Moreover, the market analysis showcases how the COVID-19 pandemic has accelerated the development and usage of therapeutic antibodies, reflecting the industry's ability to rapidly respond to emergent health issues.

Within the report, advancements in antibody engineering are emphasized, demonstrating how novel antibody formats and improvements in specificity and affinity lead to enhanced therapeutic interventions. These developments are poised to further revolutionize healthcare outcomes, offering tailored treatments with minimal side effects.

Strategic industry analysis through SWOT and Porter's Five Forces is included, equipping stakeholders with essential tools for decision-making. The attractiveness of the market is assessed by region, services, and other crucial categories.

The report also tracks competitive strategies, mergers and acquisitions, and new product developments among key players in the market. Through a careful examination of industry trends, drivers, and challenges, the report provides an insightful forecast and analysis that bolsters understanding of the Global Therapeutic Antibody Market's future trajectory.

Key Attributes:

Report Attribute Details
No. of Pages 260
Forecast Period 2024 - 2029
Estimated Market Value (USD) in 2024 $251.77 Billion
Forecasted Market Value (USD) by 2029 $428.2 Billion
Compound Annual Growth Rate 11.2%
Regions Covered Global

Companies Mentioned

Key Market Insights

The research offers a detailed analysis of the therapeutic antibody market by product type:

It also examines the source of antibodies:

And it explores various applications:

For more information about this report visit https://www.researchandmarkets.com/r/g6rvnv

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

These press releases may also interest you

at 09:30
LiveOnNY, the federally designated organ procurement organization (OPO) for the NY Metro region announce strategic collaboration with the National Association of Health Services Executives New York Regional Chapter (NAHSE NYR) to increase organ, eye...

at 09:30
Originally founded in Texas, leading massage and wellness franchise, Massage Heights, inks a multi-unit agreement to continue expanding in their home state. The two new locations will provide an elevated experience to those in the Dallas-Fort Worth...

at 09:30
Annovianttm, Inc., a pioneering company with a breakthrough TxGuardtm technology platform for soft-tissue healing, currently focused on cardiovascular field, proudly announces receipt of a $2.99 million grant (SBIR Phase 2b) from the National...

at 09:27
Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, today announced the 2024 class of Harrington Scholar-Innovators. The scholar awards will support breakthrough new treatments for heart disease, autoimmune disorders, cancer,...

at 09:27
BioArctic AB (publ) hereby announces that the Nomination Committee for BioArctic AB (publ) presents the following proposals regarding the resolution on the number of board members and the election of board members and Chairperson of the Board at the...

at 09:24
Rä Foods, a pioneer in food tech and functional foods, recently announced that its Wild About Sprouts brand is continuing its robust national expansion through a distribution agreement with Sprouts Farmers Market, starting with 134 Sprouts Farmers...

News published on and distributed by: